fda semaglutide compounding enforcement october 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified Compounded Semaglutide: Legal & Safe

Reductions in BW, and in particular muscle mass, may affect plasma creatinine levels without real changes in GFR, because skeletal muscle is the main source of creatinine

Read on as we break down the latest news about the Wegovy pill, including how it works for weight loss , possible side effects, and how much oral Wegovy might cost you out-of-pocket

This study found no association between GLP-1RAs and intestinal obstruction, while DPP-4 inhibitors were associated with an increased risk of obstruction

Given the first-line treatment protocol for NAFLD is weight management, diet and exercise, access to primary care and general health literacy is critical for diagnosing, treating and reversing the impacts of the condition

WEIGHT-LOSS DRUGS IMPACT ON CANCER RISK REVEALED IN NEW STUDY After starting the weight-loss medications, the participants weekly average alcohol intake decreased by almost two-thirds overall from approximately 11 units of alcohol to four units after four months of treatment with the GLP-1 agonists